CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+T Cell Precursors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD4-Directed Peptide Vaccination Augments an Antitumor Response, but Efficacy Is Limited by the Number of CD8+T Cell Precursors

Published:2004-03-19 Issue:7 Volume:172 Page:4215-4224
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Hanson Holly L.,Kang Silvia S.,Norian Lyse A.,Matsui Ken,O’Mara Leigh A.,Allen Paul M.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference57 articles.

1. Progress in human tumour immunology and immunotherapy

2. Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?

3. MHC Class II–Restricted Tumor Antigens Recognized by CD4+ T Cells: New Strategies for Cancer Vaccine Design

4. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

5. Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA Therapeutic Vaccine for Hepatitis B Demonstrates Immunogenicity and Efficacy in the AAV-HBV Mouse Model;Vaccines;2024-02-25

2. Mechanism of Qizhen decoction-mediated maturation of DC cells to activate the IL-12/JAK2/STAT4 pathway to sensitise PD-1 inhibitors in the treatment of colorectal cancer;Journal of Ethnopharmacology;2024-02

3. Effect Model of PD-1 Inhibitors on Immune Metabolism of Mito+ T Lymphocytes in Patients with Non-Small Cell Lung Cancer;Advances in Clinical Medicine;2023

4. CC-01 (chidamide plus celecoxib) modifies the tumor immune microenvironment and reduces tumor progression combined with immune checkpoint inhibitor;Scientific Reports;2022-01-20

5. The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment—Review;Frontiers in Immunology;2019-09-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3